Philippe Moreau, Halyna Pylypenko, Sebastian Grosicki, Ievgenii Karamanesht, Xavier Leleu, Grigoriy Rekhtman, Zvenyslava Masliak, Pawel Robak, Dixie-Lee Esseltine, Huaibao Feng, William Deraedt, Helgi van de Velde, and Bertrand Arnulf. 2015. “Subcutaneous Versus Intravenous Bortezomib in Patients With Relapsed Multiple Myeloma: Subanalysis of Patients With Renal Impairment in the Phase III MMY-3021 Study”. Haematologica 100 (5). Pavia, Italy, e207-e210. https://doi.org/10.3324/haematol.2014.118182.